// App-Quantinova.ai

: Whole Exome Sequencing of Residual Disease in Multiple Myeloma: Searching for Novel Therapeutic Targets

Researchers

Presenter

  • Martina Ztopkov

Principal Investigators

  • Tereza Sevcikova

  • Zuzana Kufova

  • Katerina Growkova

  • Jana Filipova

  • Tomas Jelinek

  • Lucie Rhov

  • Renata Bezdekov

  • Fedor Kryukov

  • Jana Smejkalov

  • Jiri Minarik

  • Vladimir Maisnar

  • Martin Mistrik

  • Ludek Pour

  • Alexandra Jungova

  • Michal imcek

  • Giovanni Stracquadanio

  • Roman Hajek

Medical Centers

  • Department of Biology and Ecology,University of Ostrava,Ostrava,Czech Republic

  • Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic

  • Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

  • Department of Clinical Hematology, University Hospital, Hradec Kralove, Czech Republic

  • Medical Department,CS BIOCAD,Saint Petersburg,Russian Federation

  • Department of Hematooncology, University Hospital Olomouc and Medical Faculty of Palacky University Olomouc, Olomouc, Czech Republic

  • Department of Urology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic

  • Department of Hematology and Transfusiology, LFUK, University Hospital Bratislava, Bratislava, Slovakia

  • Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic

  • Department of Pneumooncology, University Hospital in Pilsen, Plzen, Czech Republic

  • School of Computer Science and Electronic Engineering, University of Essex, Colchester, United Kingdom

Locations

  • Czech Republic

  • Russia

  • Slovakia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 38

  • Cluster of differentiation 45

  • Cluster of Differentiation 56

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A